nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0882	0.205	CbGbCtD
Ketoprofen—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0775	0.18	CbGbCtD
Ketoprofen—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0761	0.177	CbGbCtD
Ketoprofen—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0643	0.149	CbGbCtD
Ketoprofen—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0615	0.143	CbGbCtD
Ketoprofen—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0371	0.0861	CbGbCtD
Ketoprofen—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0263	0.0611	CbGbCtD
Ketoprofen—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000325	0.000715	CcSEcCtD
Ketoprofen—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000325	0.000714	CcSEcCtD
Ketoprofen—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000325	0.000714	CcSEcCtD
Ketoprofen—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000325	0.000714	CcSEcCtD
Ketoprofen—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000325	0.000714	CcSEcCtD
Ketoprofen—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000324	0.000712	CcSEcCtD
Ketoprofen—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000324	0.000711	CcSEcCtD
Ketoprofen—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.00071	CcSEcCtD
Ketoprofen—Headache—Tretinoin—peripheral nervous system neoplasm	0.000323	0.00071	CcSEcCtD
Ketoprofen—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000323	0.00071	CcSEcCtD
Ketoprofen—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000323	0.000709	CcSEcCtD
Ketoprofen—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000322	0.000708	CcSEcCtD
Ketoprofen—Constipation—Vincristine—peripheral nervous system neoplasm	0.000322	0.000708	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000708	CcSEcCtD
Ketoprofen—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000322	0.000708	CcSEcCtD
Ketoprofen—Rash—Melphalan—peripheral nervous system neoplasm	0.000321	0.000705	CcSEcCtD
Ketoprofen—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000321	0.000705	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.000702	CcSEcCtD
Ketoprofen—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000698	CcSEcCtD
Ketoprofen—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000317	0.000698	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000696	CcSEcCtD
Ketoprofen—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000314	0.000691	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000689	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000683	CcSEcCtD
Ketoprofen—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00031	0.000683	CcSEcCtD
Ketoprofen—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.000682	CcSEcCtD
Ketoprofen—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.000679	CcSEcCtD
Ketoprofen—Nausea—Topotecan—peripheral nervous system neoplasm	0.000309	0.000679	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000308	0.000677	CcSEcCtD
Ketoprofen—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000677	CcSEcCtD
Ketoprofen—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000308	0.000676	CcSEcCtD
Ketoprofen—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000306	0.000673	CcSEcCtD
Ketoprofen—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.000673	CcSEcCtD
Ketoprofen—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000305	0.000671	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000303	0.000667	CcSEcCtD
Ketoprofen—Infection—Etoposide—peripheral nervous system neoplasm	0.000303	0.000666	CcSEcCtD
Ketoprofen—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000302	0.000665	CcSEcCtD
Ketoprofen—Nausea—Melphalan—peripheral nervous system neoplasm	0.000302	0.000665	CcSEcCtD
Ketoprofen—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000661	CcSEcCtD
Ketoprofen—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000299	0.000657	CcSEcCtD
Ketoprofen—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000299	0.000657	CcSEcCtD
Ketoprofen—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000298	0.000654	CcSEcCtD
Ketoprofen—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000298	0.000654	CcSEcCtD
Ketoprofen—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000297	0.000653	CcSEcCtD
Ketoprofen—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000295	0.000648	CcSEcCtD
Ketoprofen—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000648	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000646	CcSEcCtD
Ketoprofen—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000291	0.000639	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000637	CcSEcCtD
Ketoprofen—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000289	0.000636	CcSEcCtD
Ketoprofen—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000288	0.000634	CcSEcCtD
Ketoprofen—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.000633	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000632	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000626	CcSEcCtD
Ketoprofen—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.000616	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000612	CcSEcCtD
Ketoprofen—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000277	0.00061	CcSEcCtD
Ketoprofen—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.000608	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000603	CcSEcCtD
Ketoprofen—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000274	0.000603	CcSEcCtD
Ketoprofen—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000274	0.000602	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000602	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.0006	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000598	CcSEcCtD
Ketoprofen—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000272	0.000598	CcSEcCtD
Ketoprofen—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000272	0.00238	CbGpPWpGaD
Ketoprofen—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000271	0.000596	CcSEcCtD
Ketoprofen—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00027	0.000594	CcSEcCtD
Ketoprofen—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000589	CcSEcCtD
Ketoprofen—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.000589	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	0.000268	0.00234	CbGpPWpGaD
Ketoprofen—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000588	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000584	CcSEcCtD
Ketoprofen—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000266	0.000584	CcSEcCtD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000265	0.00233	CbGpPWpGaD
Ketoprofen—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000265	0.000583	CcSEcCtD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000264	0.00231	CbGpPWpGaD
Ketoprofen—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000579	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000263	0.000579	CcSEcCtD
Ketoprofen—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000263	0.000578	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000574	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000574	CcSEcCtD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000261	0.00229	CbGpPWpGaD
Ketoprofen—Constipation—Etoposide—peripheral nervous system neoplasm	0.000261	0.000573	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000573	CcSEcCtD
Ketoprofen—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.000568	CcSEcCtD
Ketoprofen—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000258	0.000566	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000565	CcSEcCtD
Ketoprofen—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000562	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000558	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000557	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000556	CcSEcCtD
Ketoprofen—CXCL8—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000253	0.00222	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000252	0.00221	CbGpPWpGaD
Ketoprofen—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000553	CcSEcCtD
Ketoprofen—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000251	0.000553	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—HRAS—peripheral nervous system neoplasm	0.000251	0.0022	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000251	0.0022	CbGpPWpGaD
Ketoprofen—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00025	0.00055	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00025	0.00219	CbGpPWpGaD
Ketoprofen—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00055	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000249	0.000548	CcSEcCtD
Ketoprofen—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000249	0.000547	CcSEcCtD
Ketoprofen—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000248	0.000546	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000545	CcSEcCtD
Ketoprofen—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.000542	CcSEcCtD
Ketoprofen—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.000541	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000541	CcSEcCtD
Ketoprofen—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000245	0.000539	CcSEcCtD
Ketoprofen—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.000538	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000244	0.00214	CbGpPWpGaD
Ketoprofen—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000536	CcSEcCtD
Ketoprofen—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000242	0.000533	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000532	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000532	CcSEcCtD
Ketoprofen—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000241	0.00212	CbGpPWpGaD
Ketoprofen—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00053	CcSEcCtD
Ketoprofen—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000241	0.00053	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00053	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000241	0.00211	CbGpPWpGaD
Ketoprofen—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000529	CcSEcCtD
Ketoprofen—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000239	0.000526	CcSEcCtD
Ketoprofen—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000239	0.000525	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000525	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000523	CcSEcCtD
Ketoprofen—Rash—Vincristine—peripheral nervous system neoplasm	0.000237	0.000522	CcSEcCtD
Ketoprofen—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000237	0.000521	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.00052	CcSEcCtD
Ketoprofen—Headache—Vincristine—peripheral nervous system neoplasm	0.000236	0.000519	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000514	CcSEcCtD
Ketoprofen—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00051	CcSEcCtD
Ketoprofen—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000232	0.00203	CbGpPWpGaD
Ketoprofen—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00051	CcSEcCtD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000232	0.00203	CbGpPWpGaD
Ketoprofen—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000509	CcSEcCtD
Ketoprofen—CXCL8—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00023	0.00201	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000229	0.002	CbGpPWpGaD
Ketoprofen—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000501	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000228	0.002	CbGpPWpGaD
Ketoprofen—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000228	0.0005	CcSEcCtD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000227	0.00199	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000227	0.00199	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000225	0.000494	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000493	CcSEcCtD
Ketoprofen—Nausea—Vincristine—peripheral nervous system neoplasm	0.000224	0.000492	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000491	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000491	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00049	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—AKT1—peripheral nervous system neoplasm	0.000222	0.00194	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000221	0.00194	CbGpPWpGaD
Ketoprofen—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000486	CcSEcCtD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000221	0.00193	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.00022	0.00193	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00022	0.00193	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00022	0.00193	CbGpPWpGaD
Ketoprofen—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000219	0.000481	CcSEcCtD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000219	0.00192	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000218	0.00191	CbGpPWpGaD
Ketoprofen—Chills—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000475	CcSEcCtD
Ketoprofen—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000216	0.000474	CcSEcCtD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.000215	0.00189	CbGpPWpGaD
Ketoprofen—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000473	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000472	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000468	CcSEcCtD
Ketoprofen—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000465	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000463	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00021	0.00184	CbGpPWpGaD
Ketoprofen—Rash—Cisplatin—peripheral nervous system neoplasm	0.00021	0.000461	CcSEcCtD
Ketoprofen—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00021	0.000461	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000461	CcSEcCtD
Ketoprofen—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000209	0.000459	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000456	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000454	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000454	CcSEcCtD
Ketoprofen—Tension—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000452	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000451	CcSEcCtD
Ketoprofen—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000447	CcSEcCtD
Ketoprofen—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000202	0.000443	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—CDKN2A—peripheral nervous system neoplasm	0.000201	0.00176	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000201	0.00176	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000201	0.00176	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.0002	0.00175	CbGpPWpGaD
Ketoprofen—Chills—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000439	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000437	CcSEcCtD
Ketoprofen—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000435	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000433	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000196	0.00172	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000196	0.00172	CbGpPWpGaD
Ketoprofen—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000427	CcSEcCtD
Ketoprofen—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000194	0.000426	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000426	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000426	CcSEcCtD
Ketoprofen—Rash—Etoposide—peripheral nervous system neoplasm	0.000192	0.000423	CcSEcCtD
Ketoprofen—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000192	0.000422	CcSEcCtD
Ketoprofen—CXCL8—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000192	0.00168	CbGpPWpGaD
Ketoprofen—Headache—Etoposide—peripheral nervous system neoplasm	0.000191	0.00042	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00042	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000418	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000417	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000415	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000414	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000414	CcSEcCtD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000186	0.00163	CbGpPWpGaD
Ketoprofen—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000407	CcSEcCtD
Ketoprofen—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000183	0.00161	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000182	0.0016	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.000182	0.00159	CbGpPWpGaD
Ketoprofen—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000399	CcSEcCtD
Ketoprofen—Nausea—Etoposide—peripheral nervous system neoplasm	0.000181	0.000398	CcSEcCtD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000181	0.00159	CbGpPWpGaD
Ketoprofen—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000398	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000395	CcSEcCtD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00018	0.00157	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000179	0.00157	CbGpPWpGaD
Ketoprofen—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000394	CcSEcCtD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000178	0.00156	CbGpPWpGaD
Ketoprofen—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000392	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000391	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—peripheral nervous system neoplasm	0.000177	0.00155	CbGpPWpGaD
Ketoprofen—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000387	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000176	0.00154	CbGpPWpGaD
Ketoprofen—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000384	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000383	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000383	CcSEcCtD
Ketoprofen—CXCL8—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000174	0.00152	CbGpPWpGaD
Ketoprofen—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000379	CcSEcCtD
Ketoprofen—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000377	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000376	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000376	CcSEcCtD
Ketoprofen—Infection—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000373	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—HRAS—peripheral nervous system neoplasm	0.000169	0.00148	CbGpPWpGaD
Ketoprofen—Shock—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00037	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000369	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000368	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000368	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000367	CcSEcCtD
Ketoprofen—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000166	0.00146	CbGpPWpGaD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000166	0.00145	CbGpPWpGaD
Ketoprofen—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000363	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000363	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000362	CcSEcCtD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000164	0.00144	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000164	0.00143	CbGpPWpGaD
Ketoprofen—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000358	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000358	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000163	0.00143	CbGpPWpGaD
Ketoprofen—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000355	CcSEcCtD
Ketoprofen—CXCL8—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000161	0.00141	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000161	0.00141	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000161	0.00141	CbGpPWpGaD
Ketoprofen—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000351	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000348	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000348	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000158	0.00138	CbGpPWpGaD
Ketoprofen—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000346	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000342	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000342	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000341	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00034	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000339	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000338	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000336	CcSEcCtD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000153	0.00134	CbGpPWpGaD
Ketoprofen—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000335	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000334	CcSEcCtD
Ketoprofen—CXCL8—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.000152	0.00133	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000152	0.00133	CbGpPWpGaD
Ketoprofen—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000332	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000331	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.00015	0.00131	CbGpPWpGaD
Ketoprofen—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000327	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000325	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000324	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000147	0.00129	CbGpPWpGaD
Ketoprofen—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000321	CcSEcCtD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000146	0.00128	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000146	0.00128	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000145	0.00127	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000317	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000143	0.00126	CbGpPWpGaD
Ketoprofen—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000315	CcSEcCtD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000143	0.00125	CbGpPWpGaD
Ketoprofen—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000312	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00031	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00031	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000141	0.00123	CbGpPWpGaD
Ketoprofen—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000309	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000307	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000306	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000139	0.00122	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000138	0.00121	CbGpPWpGaD
Ketoprofen—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000302	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.0003	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.0003	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000299	CcSEcCtD
Ketoprofen—CXCL8—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000136	0.00119	CbGpPWpGaD
Ketoprofen—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000135	0.00119	CbGpPWpGaD
Ketoprofen—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000297	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000135	0.00119	CbGpPWpGaD
Ketoprofen—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000297	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000135	0.00118	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000132	0.00116	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000132	0.00116	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000287	CcSEcCtD
Ketoprofen—CXCL8—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00013	0.00114	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00013	0.00114	CbGpPWpGaD
Ketoprofen—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000284	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000129	0.00113	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000277	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000276	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000275	CcSEcCtD
Ketoprofen—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000124	0.00108	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000124	0.00108	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000123	0.00108	CbGpPWpGaD
Ketoprofen—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00027	CcSEcCtD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000123	0.00107	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000121	0.00106	CbGpPWpGaD
Ketoprofen—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000266	CcSEcCtD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000119	0.00105	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000118	0.00104	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000118	0.00103	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000118	0.00103	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000118	0.00103	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	0.000118	0.00103	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	0.000117	0.00103	CbGpPWpGaD
Ketoprofen—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000257	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000256	CcSEcCtD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000115	0.00101	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000114	0.000995	CbGpPWpGaD
Ketoprofen—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00025	CcSEcCtD
Ketoprofen—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000113	0.000993	CbGpPWpGaD
Ketoprofen—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000249	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	0.000113	0.000988	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000113	0.000988	CbGpPWpGaD
Ketoprofen—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000246	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—TP53—peripheral nervous system neoplasm	0.000112	0.00098	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000111	0.000974	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00011	0.000964	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000109	0.000956	CbGpPWpGaD
Ketoprofen—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000239	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	0.000109	0.000951	CbGpPWpGaD
Ketoprofen—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000238	CcSEcCtD
Ketoprofen—Rash—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000237	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000237	CcSEcCtD
Ketoprofen—Headache—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000235	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000107	0.000934	CbGpPWpGaD
Ketoprofen—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000106	0.00093	CbGpPWpGaD
Ketoprofen—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00023	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000105	0.000916	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000103	0.000904	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000103	0.000902	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000103	0.000902	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000103	0.000901	CbGpPWpGaD
Ketoprofen—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000223	CcSEcCtD
Ketoprofen—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000221	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000219	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000219	CcSEcCtD
Ketoprofen—CXCL8—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.93e-05	0.00087	CbGpPWpGaD
Ketoprofen—Headache—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000218	CcSEcCtD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.87e-05	0.000865	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.83e-05	0.000861	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.68e-05	0.000849	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.63e-05	0.000844	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.48e-05	0.000831	CbGpPWpGaD
Ketoprofen—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000207	CcSEcCtD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.28e-05	0.000813	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.1e-05	0.000798	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	9.08e-05	0.000796	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.02e-05	0.00079	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	8.95e-05	0.000784	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	8.85e-05	0.000776	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	8.59e-05	0.000753	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	8.58e-05	0.000752	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	8.55e-05	0.00075	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—GNS—peripheral nervous system neoplasm	8.48e-05	0.000743	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—peripheral nervous system neoplasm	8.45e-05	0.000741	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.35e-05	0.000732	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	8.26e-05	0.000724	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	8.24e-05	0.000723	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.2e-05	0.000719	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.17e-05	0.000716	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.99e-05	0.000701	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.95e-05	0.000697	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.48e-05	0.000656	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	7.13e-05	0.000625	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.12e-05	0.000624	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	7.1e-05	0.000623	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	7.05e-05	0.000618	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	6.87e-05	0.000602	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	6.81e-05	0.000597	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.64e-05	0.000582	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.61e-05	0.000579	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	6.56e-05	0.000575	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.51e-05	0.00057	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.48e-05	0.000568	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.45e-05	0.000565	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	6.37e-05	0.000558	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.27e-05	0.000549	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.11e-05	0.000535	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.09e-05	0.000534	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	6.02e-05	0.000528	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.99e-05	0.000525	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.94e-05	0.000521	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	5.93e-05	0.00052	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.89e-05	0.000516	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.84e-05	0.000512	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.81e-05	0.000509	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	5.78e-05	0.000507	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNS—peripheral nervous system neoplasm	5.75e-05	0.000504	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.74e-05	0.000503	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	5.66e-05	0.000496	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	5.57e-05	0.000488	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	5.54e-05	0.000486	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NME1—peripheral nervous system neoplasm	5.51e-05	0.000483	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	5.42e-05	0.000475	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.41e-05	0.000474	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.39e-05	0.000473	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	5.33e-05	0.000468	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.33e-05	0.000467	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	5.31e-05	0.000465	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—COX2—peripheral nervous system neoplasm	5.3e-05	0.000465	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	5.14e-05	0.000451	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	5.14e-05	0.00045	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.93e-05	0.000432	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.82e-05	0.000423	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.8e-05	0.00042	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.73e-05	0.000415	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	4.7e-05	0.000412	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.62e-05	0.000405	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.59e-05	0.000403	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	4.58e-05	0.000401	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.54e-05	0.000398	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	4.51e-05	0.000395	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.37e-05	0.000383	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	4.34e-05	0.000381	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	4.31e-05	0.000377	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	4.3e-05	0.000377	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	4.14e-05	0.000363	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.05e-05	0.000355	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	3.93e-05	0.000345	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.87e-05	0.000339	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.77e-05	0.000331	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.77e-05	0.00033	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	3.76e-05	0.00033	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.7e-05	0.000325	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	3.64e-05	0.000319	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.61e-05	0.000316	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	3.52e-05	0.000308	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	3.5e-05	0.000307	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	3.48e-05	0.000305	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.47e-05	0.000304	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.45e-05	0.000302	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	3.42e-05	0.0003	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	3.32e-05	0.000291	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.19e-05	0.000279	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	2.96e-05	0.000259	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	2.94e-05	0.000258	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.93e-05	0.000256	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.92e-05	0.000256	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	2.85e-05	0.00025	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.82e-05	0.000247	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.81e-05	0.000246	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	2.79e-05	0.000245	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	2.78e-05	0.000244	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TH—peripheral nervous system neoplasm	2.77e-05	0.000242	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.76e-05	0.000242	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.74e-05	0.00024	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.68e-05	0.000235	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.66e-05	0.000233	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.43e-05	0.000213	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.41e-05	0.000211	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	2.33e-05	0.000204	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	2.32e-05	0.000203	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.3e-05	0.000201	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	2.27e-05	0.000199	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.26e-05	0.000198	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	2.26e-05	0.000198	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.23e-05	0.000195	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.23e-05	0.000195	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	2.22e-05	0.000194	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.07e-05	0.000182	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.85e-05	0.000162	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	1.83e-05	0.00016	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.81e-05	0.000159	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.78e-05	0.000156	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.7e-05	0.000149	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.7e-05	0.000149	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.63e-05	0.000143	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.5e-05	0.000132	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.44e-05	0.000126	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	1.39e-05	0.000122	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—peripheral nervous system neoplasm	1.3e-05	0.000114	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000109	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	1.02e-05	8.93e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	9.49e-06	8.32e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	9e-06	7.88e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	7.53e-06	6.6e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	6.13e-06	5.37e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	6.1e-06	5.34e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	4.99e-06	4.37e-05	CbGpPWpGaD
